Cite
MLA Citation
S. Z. Usmani et al.. “P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA.” HemaSphere, vol. 6, n.d., pp. 832–833. http://access.bl.uk/ark:/81055/vdc_100159756131.0x000019